Anthropic has acquired Coefficient Bio, an artificial intelligence (AI) BioTech startup founded last fall, for about $400 million, The Information reported Thursday (April 2), citing an unnamed source. The Coefficient Bio team, which includes fewer than 10 employees and was developing a platform that uses AI for planning drug research and development, managing clinical regulatory strategy and identifying new drug opportunities, will join Anthropic’s healthcare life sciences group, according to the report. Pymnts reported in January that Anthropic is pushing deeper into life sciences. Through Claude for Life Sciences, the company is positioning its models as research partners embedded in scientific environments and connected to platforms like PubMed, Benchling and ClinicalTrials.gov. The focus is on biomedical research tasks such as literature synthesis, hypothesis generation, clinical trial planning and regulatory documentation.

Full report : Anthropic has acquired Coefficient Bio, which was developing a platform that enables AI to run biotech tasks such as planning drug research, for ~$400 million.